The results are in – and I am delighted to announce that MTPConnect’s Targeted Translation Research Accelerator (TTRA) program for diabetes and cardiovascular disease is already delivering benefits and novel health solutions for Australian patients and the health sector. And it’s just over halfway through its duration. The
$47 million TTRA program, an initiative of the Medical Research Future Fund (MRFF), was established by MTPConnect in 2020 to support translational research for the development of novel products and solutions for diabetes and cardiovascular disease – leading causes of death and disability in Australia. This month we published a new report, ‘Transforming health outcomes for diabetes and cardiovascular disease in Australia – Interim report on impacts of the first Targeted Translation Research
Accelerator’, that captures the achievements to date of the two national Research Centres established – the Australian Centre for Accelerating Diabetes Innovations (ACADI) and the Australian Stroke and Heart Research Accelerator (ASHRA) – and the 22 individual Research Projects funded. While the TTRA program is still in its infancy, it’s impressive that tangible impacts and economic growth are already being delivered. To date, 46 new products, solutions and technologies now progressing towards translation, three new spin-out companies formed, 17 pre-clinical and clinical trials commenced and 459 trial participants recruited. Innovations supported by our diabetes and cardiovascular disease accelerator include an oral insulin drug delivery platform, a total artificial heart controller, antithrombotic therapies for better stroke treatment, technology to detect unstable coronary plaques, as well as the world's first national helpline providing mental health support via telehealth directly to adults with diabetes and cardiovascular disease. It’s proof that the government’s MRFF investment is a catalyst for accelerating outstanding results that will change the lives of people
living with diabetes and cardiovascular disease. Successfully steering a translation program of this scale is not possible without deep management and partnership expertise, and I’d like to acknowledge our talented TTRA team of Lauren Kelly, Dr Mana Liao and Dr Erin McAllum for their hard work and dedication. I’d also like to acknowledge the Research Centres and Research Projects funded through the TTRA, whose groundbreaking work forms the basis for the outcomes and impacts described in the report, and the TTRA Partners
- ANDHealth, AusHSI, The Lowitja Institute, Medical Device Partnering Program and UniQuest, whose dedication has helped them achieve this. There is more to do, but we’re excited to see what else TTRA can achieve to improve the lives of those living with diabetes and cardiovascular disease. Funding opportunities to support the translation of innovative research is a hot topic. Today we are kicking off a sold-out networking event for the first SA Insights Series for 2024, focused on the changing funding landscape for start-ups and SMEs. Our Adelaide team has pulled together a group of leaders representing the national funding programs that drive Australia's healthtech innovations, and we plan to share the event with you in a special episode of the MTPConnect Podcast due out next month. And the next SA Insight Series event in March continues this funding theme, delving into the dynamic world of healthtech investment with guests from Brandon Capital, Artesian, Southern Angels, Radium Capital, and Endpoints Capital, so register to attend in Adelaide if you can. This month’s MTPConnect Podcast episode takes you behind our Clinical Translation and Commercialisation Medtech (CTCM) accelerator program to meet some of Australia’s trailblazing medtech companies benefiting from MRFF funding and support. Find out how they are managing their innovation and commercialisation
journeys. With our eyes on international investment and partnering opportunities, our plans are progressing for the Australian mission to BIO2024 which takes place in San Diego from 3-6 June. Our team is busy creating a stand-out Australian Pavilion as a meeting place to do business at the world’s largest biotechnology business partnering event. And we are curating an international welcome event to connect international prospects with Australian research and industry capabilities. We were able to secure a limited number of
discounted registrations for the Australian delegation and these will be allocated across every state so if you plan to attend BIO, please look out for more information on that opportunity. Remember to register for the conference with early bird rates ending early March. If you’re a SA or WA-based company heading to BIO, it’s time to start prepping. Our WA Life Sciences Innovation Hub and Adelaide Intermediary Program will be holding a number of Preparing for Partnering events for delegates over the next few months, kicking off with a webinar in March focusing on Planning for a Productive Conference. Finally, we are delighted to once again be supporting the Address to the National Press Club as part of Science and Technology Australia’s Science Meets Parliament event in Canberra. Join us on 20 March to hear from STA President Professor Sharath Sriram or check out the televised event on the ABC. With so much happening in the sector, our newsletter below is a great way of keeping up to date on opportunities, events, and news. We
look forward to connecting with you soon. Kind regards, Stuart Dignam
Chief Executive Officer
MTPConnect & Industry News
Early Results Are In – TTRA Program is Delivering Impact at Halfway Mark
MTPConnect has published a new report, ‘Transforming health outcomes for diabetes and cardiovascular disease in Australia – Interim report on impacts of the first Targeted Translation Research Accelerator' which shows MTPConnect’s Targeted Translation Research Accelerator (TTRA) program for diabetes and cardiovascular disease is already delivering benefits and novel health solutions for Australian patients and the health sector – just over halfway through its duration. The report captures the
achievements to date of the two national Research Centres established – the Australian Centre for Accelerating Diabetes Innovations (ACADI) and the Australian Stroke and Heart Research Accelerator (ASHRA) – and the 22 individual Research Projects funded, which have been collectively awarded $38.3 million in competitive funding. Join Australia's mission to BIO2024 in San Diego - Limited Discounted Registrations
MTPConnect is excited to lead this year’s BIO2024 mission to San Diego from 3 – 6 June 2024 to showcase Australia’s outstanding life science innovations, innovators and unique biotechnology, pharmaceutical and manufacturing capabilities. The BIO conference is the largest biotechnology business partnering event in the world. MTPConnect is hosting the Team Australia pavilion and the Australian Welcome and Business Reception. MTPConnect in partnership with BIO is offering a limited number of discounted registrations for companies in the Australian Delegation attending BIO2024 Convention in San Diego. But get in quick by registering your interest now with your State rep! Check out the key dates, and find out how your organisation can be involved in your State’s key activities! Register Your Interest for SA Delegation to BIO2024
Invest SA - Department for Trade and Investment (DTI), invites you to join the South Australian delegation travelling to the BIO International Convention 2024. The South Australian Government is supporting South Australian stakeholders' as part of a collaborative national approach, including promotion, activities, booth and supporting resources. To join the delegation, register via email here or register your interest with SA Delegate. Preparing for Partnering - Get Ready for BIO2024!
For SA and WA-based delegates heading to the BIO Convention, join the Preparing for Partnering workshops delivered by MTPConnect to learn tips and tricks to secure and hold effective partnering meetings at major conventions. Register for the online event, Planning for a Productive Conference, on 15 March 2024. The second information session, Pitching to Your Audience, will be held in Adelaide on 1 May 2024 - learn how to tailor your pitch presentation and host a productive meeting to ensure that you make a lasting impression. Join the SA Delegation to BIO Korea 2024
Invest SA - Department for Trade and Investment (DTI), invites you to join the South Australian delegation travelling to BIO KOREA 2024. Register your interest. SA Insights Highlights Healthtech Investment Landscape
Entrepreneurs, innovators, and companies! Delve into the dynamic world of healthtech investment at Adelaide Intermediary Program's upcoming SA Insights event with Dr Natalie Rickers in a fireside chat with five distinguished guests including, Melissa McBurnie, Partner & Head of Impact at Brandon Capital, Stephanie Morris, Investment Manager at Artesian, JD Sheard from Southern Angels, Roy Smith, State Manager at Radium Capital, and Andrew Stewart, CEO of Endpoints Capital. On Thursday 21 March, 5.30 pm - 7.30 pm ACDT. Register now! WA Life Sciences Innovation Hub Seminar in March
The WA Life Sciences Innovation Hub invites you to a special seminar event with international biotech consultant Dr Kate Hilyard, Translating complexity - getting rid of the jargon that often puts barriers between us. Kate has extensive experience translating complexity in roles at iHealx and the UK Vaccine Task Force working with government, science and business stakeholders. Join the conversation on Wednesday 27 March at the Harry Perkins Institute of Medical Research in Nedlands.
Connect with the Adelaide Intermediary Program's Fee-Free Services
Would you like to elevate your research impact, build connections and access advice to identify funding opportunities? MTPConnect's Adelaide Intermediary Program team will be working from the Tonsley Innovation District on the first Thursday of each month for drop-ins or one-on-one consultations. Access the fee-free services of the Adelaide Intermediary Program now. Book a meeting. Season Six of MTPConnect Podcast Kicks off with CTCM Medtech Trailblazers
The sixth season of the popular MTPConnect podcast has kicked off this year with a focus on Australian medtech trailblazers! We meet Eudaemon Technologies, CathRx, Ventora Medical, LBT Innovations, and 4DMedical to find out more about the support they need to commercialise their medical devices, and how our CTCM program and MRFF funding is making a difference! Listen here! Early Bird Registrations Open for AustMedtech 2024 - Book a Tour!
Register for the AusMedTech 2024 Conference in Adelaide on 22-23 May at the Adelaide Convention Centre. MTPConnect's Adelaide Intermediary Program team, with support from the Department for Trade and Investment, will be hosting 4 guided tours of SA's Innovation Districts. Registered delegates can sign-up to, 'Discover SA’s MedTech, People, Places, and Opportunities'. Site Options include, Adelaide Biomed City, Lot Fourteen, Tonsley Innovation District and ANFF South Australia (Mawson Lakes). Grab your early bird tickets before 29 March 2024! Pathology Technology Australia Presents PTA Congress 2024
MTPConnect is proudly supporting Pathology Technology Australia's PTA-C/24 Expo, bringing together stakeholders to address some of the big health system challenges we face, on 11 - 13 March 2024 in Sydney. Read the program and register! WACHCI Expert Workshop Series in Perth
Delivered in collaboration with the WA Life Sciences Innovation Hub, a partnership between MTPConnect, the Department of Health (WA Health) and The University of Western Australia, ANDHealth presented the fourth instalment of the WA Connected Health Commercialisation Initiative Expert Workshop Series, 'The Digital Health Evolution and Surviving Due Diligence'. It was an insightful presentation with valuable advice from international guest, Lisa Suennen, followed by an engaging "Ask us Anything" session with ANDHealth CEO Bronwyn Le Grice. SA insights Series 2024: Funding Programs That Drive Australia's Healthtech Innovations
Entrepreneurs, inventors, companies and researchers in the healthtech sector looking to learn more about the funding ecosystem in Australia gathered for The Adelaide Intermediary Program's first SA Insights event of the year. The event featured insights into the funding programs that drive Australia's healthtech innovations with six distinguished leaders each representing national funding programs. Stay tuned for our upcoming podcast episode recorded at the event! SA's Global Market Navigator Program Lifts Off
Congratulations to the Adelaide-based healthtech businesses who were selected to participate in the inaugural Global Market Navigator Program, including Personify Care, Sementis, Fusetec 3D, Osteo-X, Protego Medical, RehabSwift, Innovatus Technology, Corcillum Systems, Addend.ai and ResearchSat. The Global Market Navigator Program is an initiative delivered by MTPConnect and supported by funding from the Adelaide Economic Development Agency (AEDA). Calling Clinician Entrepreneurs to Join ASME
Are you a clinician wanting to transform healthcare through innovation - join the Australian Society for Medical Entrepreneurship & Innovation. Backed by a committee of 'medical entrepreneurs' with diverse skills and backgrounds, it's a home created for doctors & other healthcare professionals to connect with medical entrepreneurs & innovators. Check out all the details on ASME website, follow on LinkedIn and join as a member for free! The Artificial Heart Frontiers Program - developing and commercialising the world’s most advanced artificial heart
The Australian Government is providing $50 million to develop and commercialise the world’s most advanced artificial heart, a technology that could halve deaths from heart failure globally. The investment from the Medical Research Future Fund (MRFF) will support the Artificial Heart Frontiers Program bringing together the Monash University-led consortium including Industry partner BiVACOR, University partners - Monash University, University of Sydney, University of New South Wales, Griffith University, and University of Queensland and Clinical partners - The Alfred, Baker Heart & Diabetes Institute and St Vincent’s Health Australia. ANDHealth Accelerator Cracks Australia’s Commercialisation Code with New Report
A new independent report by ANDHealth and published by L.E.K. Consulting, the ‘Economic impact assessment of ANDHealth+ and Masterclass: ACCELERATE programs’ found that for every $1 invested into ANDHealth’s flagship accelerator, ANDHealth+, $19.70 in capital is raised and $4.2 in gross economic value is delivered by digital health SMEs. And for every $1 million invested, 56 jobs are created. MTPConnect was delighted to support the development of the report, and CEO Stuart Dignam joined ANDHealth CEO Ms Le Grice at Parliament House to speak about the importance of health innovation accelerator programs in driving jobs and growth in Australia. Sector Snapshot- U.S.- and Australia-based CRO Avance Clinical has inked a deal with Ryght to use the generative artificial intelligence provider’s tech for clinical trial processes, the companies announced
- Read our new report out now, ‘Transforming health outcomes for diabetes and cardiovascular disease in Australia – Interim report on impacts of the first Targeted Translation Research Accelerator’
- Exciting news for our friends at BiVACOR Inc, announced as the industry partner in the $50M initiative to bring their total artificial heart (TAH) to people with serious heart failure. MTPConnect is supporting BiVACOR through its TTRA accelerator program for diabetes and cardiovascular disease, also made possible by the MRFF, to develop a long-term controller to power and run the TAH
- Check out the MTPConnect 2023 Annual Report - out now!
- Read the new report from MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet): Fighting superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections developed by Evohealth
- Franklin Women and Organon is partnering to launch Members Connect series to strengthen networks and drive career opportunities for women in science
- Recce Pharmaceuticals has established a strategic partnership with leading Indonesian biomedical company, PT Etana Biotechnologies, to accelerate its clinical program
- Register now for the NSW Women in Life Sciences Luncheon 2024 in Sydney on Friday 8 March 2024,
co-hosted by AusBiotech and Medicines Australia
- Congratulations to the four digital health companies, Macuject, Baymatob, Neurotologix and WeGuide who will receive $3.25M through ANDHealth+ program to support their AI-powered technologies to hit clinical and commercial milestones as they seek to export Australian digital health products to global markets
- BioMelbourne Network has announced an MOU and partnership with leading state industry associations BioNSW and Life Sciences Queensland Ltd (LSQ)
- Biomebank has received a multimillion-dollar grant from the Australian Government's Cooperative Research Centres Projects (CRC-P) to develop a
manufacturing facility for cultured microbial therapeutics in Adelaide, Australia. The project is a collaborative partnership between BiomeBank, Cytiva, and the Hudson Institute of Medical Research
- Congratulations to Neuromersiv who has announced a partnership with the Stroke Foundation to undertake joint educational activities throughout 2024 aimed at raising awareness of the transformative potential of VR rehabilitation therapy among healthcare professionals, stroke survivors, and their
families
- Bioxyne (BXN) has been awarded Australia's first GMP manufacturing license for medical cannabis, Psilocybin and MDMA
- The Federal Government has released its Pathway to Diversity in STEM report, check out the recommendations!
- Ivan Power has been appointed as the Chief Executive Officer (CEO) of the National Reconstruction Fund Corporation (NRFC)
- Congratulations to
Perth-based biotech company Argenica Therapeutics who is trialling a new groundbreaking drug in hospitals across Australia to reduce brain tissue damage following a stroke
- Peter Traianou has joined the Board of Directors at VeinTech as Non-Executive Chair
- Rebecca Tomkinson has been appointed as the new Chair of the WA Government's Future Health Research and Innovation (FHRI) Fund Advisory Council
Dr Nick
Hunt, a Targeted Translation Research Accelerator (TTRA) awardee, chats to the Research Bytes podcast about teamwork which led to groundbreaking discoveries on the development of oral insulin which could dramatically improve the lives of diabetics Congratulations to The Australian Centre for Accelerating Diabetes Innovations (ACADI) for securing a groundbreaking grant funded by the MRFF's Preventive and Public Health Research
Initiative! - Check out the free recording of BioMelbourne's mRNAVic Series 2 Lecture - The RNA Platform: The Breadth of Possibility Beyond on the BioResource Hub
- VividWhite has been awarded ANFF-C Gate 2 pre-seed funding to aid in the commercialisation of VividFlo, a revolutionary microfluidic medical device for glaucoma treatment. Vivid White has received funding support from our Clinical Translation and Commercialisation Medtech Program
- BMTH awardee Macuject has announced two in-market Optometry and Ophthalmology pilots launching in the US this year,
while also commencing FDA pre-submission regulatory activities.
- Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, announced the acquisition of an equity stake in ACQUANDAS
- Check out the 'Discovery to Device' facility for accelerating MedTech commercialisation, in partnership with RMIT and the Victorian Government. Contact Professor Sharath Sriram to find out more
- AARMNet has a LinkedIn page so you can now follow for updates about the antimicrobial resistance ecosystem!
- Our Adelaide Intermediary Program (AIP) has a dedicated LinkedIn page. Follow along for updates on SA's health and medical innovations sector!
- To find out what's happening in the WA sector, you can follow the WA Life Sciences Innovation Hub directly on LinkedIn
- Read the National Action Plan to Build Australia’s
Diagnostic Technology Sector and Improve Health Security
- Read the BMTH Impact report launched in August 2023, highlighting the progress and impact of 38 medical device projects that have completed phase two of MTPConnect's BioMedTech Horizons program
- The Victorian Government has
produced the Victorian Medtech Capability Directory.
- gemaker's website is a great resource for the innovation and commercialisation sector
- Join the mailing list of the new Victorian Medtech Skills and Device Hub, bringing together local businesses, universities and education providers to accelerate Victoria's medtech sector and deliver the workforce of the future
- Read the BTB Impact Report summarising the progress and impact of 21 projects that have completed MTPConnect's Biomedical Translation Bridge program
Sector Opportunities - Applications are open for round 25 of the Cooperative Research Centres (CRC) Grants The grants provide funding for medium to long-term, industry-led research collaborations. Apply before 5 March 2024
- Are you a non-European business looking to enter the European market? Join Exportia's Christelle Damiens for the Virtual Book Launch : Is it time to start exporting to Europe? on 5 March 2024
- The MRFF Indigenous Health Research Fund – 2023 Indigenous Health Research Grant Opportunity is open until 6 March 2024
- Do you know an outstanding scientist, innovator or science communicator? Enter or nominate before 12 April for the 2024 Eureka Prizes. A free, 45-minute, online information session for prospective entrants will be hosted from 12pm AEST Friday 1 March. Join this session to learn more about the prize categories, submission process and tips for writing a strong application program
- Check out the APR.Intern internships available in the MTP Sector!
- AstraZeneca’s next round of its research collaboration challenge is now open. CoSolve, a biannual, global Open Innovation programme, is seeking collaborators who can bring innovative ideas that can be rapidly translated into tangible solutions. Apply by 6 March 2024
- The next WA Government’s Future Health Research and Innovation (FHRI) Fund Open Day will be held on 8 March 2024 in Karratha and online, providing information about WA health and medical research and innovation developments, the FHRI Fund programs open for applications, and recently awarded FHRI Fund grant recipients
- JPIAMR has launched an international call for projects to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments, involving 21 funders from 19 countries. Submit pre-proposals by 14 March 2024 and full proposals by 9 July 2024
- Applications are open until 15 March for the National Industry PhD
Program. The program helps PhD candidates transform their research into new products and services
- Apply for the 2024 Perth Biodesign Course! by 17 March 2024
- Deep Tech Elevate is an immersive 2-day workshop with a supporting e-learning course designed to empower deep tech startups and propel your businesses along the commercialisation journey, designed and delivered by Cicada Innovations on 27-28 March in Sydney
Nominations are now open for the 2024 ACTA Trial Of The Year Awards, honouring Australians who make notable contributions to enhancing our healthcare system by pioneering, implementing, or participating in groundbreaking clinical trials. Nominations close midnight, 29 March 2024 - Applications for Round 12 of the Medical Devices Fund are now open. Eligible applicants can apply for $500,000 - $5,000,000 (excluding GST) per application, to
progress their medical devices and related technologies towards commercialisation. Closes 29 March 2024
- The Commercialisation Bridge Grant (CBG) is a new Western Australian government grant designed to help WA innovators bridge the ‘Valley of Death’ between a commercialised innovation and a sustainable, scalable business. The FY2023/24 submissions cut-off date is 4 April 2024
The WA Near-miss Awards is another FHRI Program providing grants for eligible near-miss applications to the 2023 National Health and Medical Research Council Ideas Grants program. Applications close 4 April 2024 The Future Health Research and Innovation (FHRI) Fund Enabling Scheme is now open! The funding will provide support for capital costs associated with undertaking health and medical research and/or innovation in Western Australia. Apply before 4 April 2024 - Apply for the health pre-accelerator program, Health Pre X which supports startups who are designing affordable and scalable solutions to unmet health and medical needs. Closes 5 April 2024
- CHI Start-up Enterprise Link (CHISEL) Healthcare InnoMatch 2024 is calling for innovative market-ready or near market-ready solutions to address critical and emerging healthcare needs! Apply by 5 April
2024
- MedChem Australia has announced its first call for project applications from researchers across Australia to facilitate the translation of cutting-edge research into tangible advancements in drug discovery. Applications close 19 April 2024
- Investment NSW's MVP Ventures Program supports startups and innovative SMEs in the product lifecycle between early-stage research and mature investment opportunities, through grants to drive the commercialisation of highly innovative and new products or processes. Applications for Round 1 close on 30 April 2024
- The NSW government and Cicada Innovations are providing nationwide access to free online commercialisation training, 'NSW Deep Tech Commercialisation Program: Foundations'.
The newly launched Victorian MedTech Market Growth Program will provide $50,000 matched funding to up to 20 medtech startups and scaleups to equip them with the skills,
services and resources they need to push their life-saving products to market. Join the information session on 7 March to find out more. Applications close 8 April 2024 The MRFF 2023 Clinical Trials Activity Grant Opportunity is open until 29 May 2024 The Aged Care Research & Industry Innovation Australia (ARIIA) x Medical device Partnering Program (MDPP) Ideas Incubator closes 31 May
2024 or until project allocation exhausted Applications are open for the MRFF Cardiovascular Health Mission – 2024 Cardiovascular Health Grant Opportunity. Apply by 3 July 2024 The MRFF – National Critical Research Infrastructure Initiative – 2023 Innovative Trials is accepting applications until 10 July 2024 Applications are now open for the Joint Programming Initiative on Antimicrobial Resistance. Apply before 11 July 2024 The MRFF 2024
Early to Mid-Career Researchers Grant Opportunity is open until 17 July 2024 The MRFF – Stem Cell Therapies Mission – 2024 Stem Cell Therapies Grant Opportunity is open until 17 July 2024 The MRFF Indigenous Health Research Fund – 2024 Indigenous Health Research Grant Opportunity closes 24 July 2024 The MRFF – Dementia, Ageing and Aged Care Mission – 2024 Dementia, Ageing and Aged Care Grant Opportunity is open. Apply by 31 July 2024 The MRFF – PPHRI – 2024 Survivorship Care and Collaborative Research Prioritisation Grant Opportunity closes 31 July 2024 The MRFF – Preventive and Public Health Research Initiative – 2024 Maternal Health and Healthy Lifestyles
Grant Opportunity closes 31 July 2024 The MRFF – PPHRI – 2024 Enhancing Medical Device Surveillance Through Registries Grant Opportunity is open. Apply by 7 August 2024 - The Manufacturing Industry Skills Alliance has launched its Initial Workforce Plan on manufacturing workforce challenges ahead of a comprehensive workforce plan being developed. Read the report. Add your insights by completing a 10-minute survey or send an email with your input
- The SA Government's Commission on Excellence and Innovation in Health is seeking your feedback on how, as a state, it can identify, develop, and mobilise innovation in public and private spheres of health care. Please take the short survey and show support for creating a culture of innovation and translation in South Australia.
- Applications
are now open for X-TEND WA, a competitive co-investment grants program, investing in organisations that deliver initiatives to assist and support the WA Innovation Ecosystem provided by WA's Department of Jobs, Tourism, Science and Innovation
- Co-Funding
Partnerships Program (Co-FPP) is an ongoing Program of the Future Health Research and Innovation (FHRI) Fund to establish collaborations and funding partnerships to bring new non-government funding for health and medical research and innovation to WA, and to build a culture that supports co-operation and interconnectedness
- For a limited time, you can read the e-book version of Innovate Adelaide
- Grant variations resources: Information and forms for varying MRFF grants
- Nominate your organisation to be included in CSIRO's NAIC's Australian AI ecosystem
discoverability platform - including a public online directory to search and find Australian AI capabilities
- Pitch to the CSIRO Innovation Fund, Main Sequence, which addresses the ‘valley of death’ between research and commercialisation
The Seed-Start program (South Australia) supports commercialisation of innovative, early-stage SA startups. Applications are ongoing - The
Industry Growth Program provides support for innovative SMEs to commercialise and grow their business within the National Reconstruction Fund priority areas, such as medical science. You will be connected to an Industry Growth Program Adviser who will provide tailored advice to support your commercialisation and/or growth project. And you may be eligible to apply for further funding. Applications are now open
- AusBiotech's newly-launched AusMedtechInvest 2024 investment roundtable is seeking EOIs from
medtech companies looking to grow and create meaningful connections with investors. Find out more!
Are you a biotech innovator looking for specialised facilities? Jumar Bioincubator, Australia's newest biotech incubator is offering affordable lab and office space, along with practical support, to nurture young biotech
ventures. Find out more Through WA Connected Health Commercialisation Initiative (a collaboration between ANDHealth and the WA Life Sciences Innovation Hub), ANDHealth is providing digital health companies the opportunity to meet them and matched industry experts to seek guidance on aspects of commercialisation
and market access. Apply for WACHCI Office Hours and ELEVATE: Skills Specific Industry Coaching Program ATSE's IMNIS Ignite is a postgraduate internship program connecting industry-ready IMNIS Engage alumni with industry-based internships at host organisations. Register your interest. Keep up with funding opportunities and subscribe to the monthly MRFF newsletter, from the Australian Government Department of Health and Aged Care Do you have a great idea for a medical or assistive device and need R&D assistance? Connect with MDPP - supported by MTPConnect's REDI initiative Subscribe to gemaker's Monthly Insights newsletter for researchers, inventors and innovative businesses List your medtech organisation on MDPP's online Capability Directory Report a Trade Barrier through the Trade Barriers Register
Events- 4 March 2024 - A physics-based physiology approach for developing the virtual human
twin, Medical Device Research Institute (Tonsley, SA)
- 7 March 2024 - NSW BioCheers at CSIRO, AusBiotech (Sydney)
- 7 March 2024 - ACMD-VMH Showcase: Innovations in Medical Technology (Melbourne)
- 7 March 2024 - NHMRC Speaking of Science Series - International Women's Day Panel (online)
- 7 March 2024 - MedTech Market Growth Program Information Session, LaunchVic (online)
- 8 March 2024 - NSW Women in Life Sciences Luncheon 2024 AusBiotech & Medicines Australia (Sydney)
- 8 March 2024 - Future Health Research and Innovation (FHRI) Fund Open Day, WA Gov (Karatha & online)
- 8-9 March 2024 - Australian Precision Oncology Symposium 2024 -APOS 2024 Omico
(Sydney)
- 11-13 March 2024 - PTA Congress 2024, Pathology Technology Australia (Pyrmont, NSW)
- 13 March 2024 - WA BioCheers, AusBiotech (Crawley, WA)
- 14 March 2024 - Future of Health - Scaling & Retaining for Biomanufacturing, Life Sciences QLD (Brookwater,
QLD)
- 14-16 March 2024 - Preceptorship 2024, ProsTIC (Melbourne)
- 15 March 2024 - Preparing for Partnering: Session 1, Planning for a Productive Conference, WA Life Sciences Innovation Hub and MTPConnect Adelaide Intermediary Program (Online)
- 18 March 2024 - BioSymposium – Crossing the Rubicon in AI Decision-Making, BioMelbourne Network (Melbourne)
- 20-21 March 2024 - Science Meets Parliament, Science & Technology Australia (Canberra)
- 20-21 March 2024 - Australian Healthcare Week (Sydney)
- 21 March 2024 - SA Insights: The Healthtech Investment Landscape, MTPConnect Adelaide Intermediary Program (Adelaide)
- 27-28 March 2024 - Deep Tech Elevate workshop, Cicada Innovations (Sydney)
- 4-5 April 2024 - Research Translation Essentials Course, Health Translation SA (Adelaide)
- 9-11 April 2024 - Pharmaceuticals and Therapeutics Specialisation course, Cicada Innovations (Sydney & online)
- 11 April 2024 - mRNA Lecture Series 2: Lecture Three: Details TBC, BioMelbourne Network (Melbourne)
- 12 April 2024 - How to turn your lab prototype into a commercially ready device, NSSN and Genesys Electronics (Sydney)
- 30 April-2 May 2024 - Medical Devices Specialisation course, Cicada Innovations (Sydney & online)
- 1 May 2024 - Preparing for Partnering: Session 2: Pitching to Your Audience, MTPConnect Adelaide Intermediary Program (Adelaide)
- 7-8 May 2024 - Digital Health Festival (Melbourne)
- 7-9 May - Diagnostics Specialisation course, Cicada Innovations
& PTA (Sydney & online)
- 17 May 2024 - Connecting Women Lunch, BioMelbourne Network (Melbourne)
- 8-10 May 2024 - Bio Korea (Korea)
- 20 May 2024 - 2024 ACTA Trial of the Year Awards, Australian Clinical Trials Alliance
- 20-21 May 2024 - 2024 BioPharmaDispatch conference (Sydney)
- 22-23 May 2024 - AusMedtech Conference, AusBiotech (Adelaide)
- 22-24 May
2024 - The Medtech Forum (Vienna)
- 28 May 2024 - mRNA Lecture Series 2: Lecture Four: details TBC, BioMelbourne Network (Melbourne)
- 28-30 May 2024 - Software as a Medical Device, Cicada Innovations & ANDHealth (Online)
- 3-6 June 2024 - BIO International Convention (San Diego, CA)
- 18-21 June 2024 - Global Health Security 2024 Conference (Sydney)
- 20-22 June 2024 -2nd Australasian Conference on Point of Care Testing for
Infectious Diseases - POC24 ASHM (Bangkok, Thailand)
- 15-17 October 2024 - The Medtech Conference (Toronto, Canada)
- 30 Nov -1 Oct 2024 - AusBiotech Conference (Melbourne)
To see what industry events are coming up in 2024, visit our events page.
Case Study Showcase | TTRA Program Springboards Spin Out Companies To Accelerate TranslationFormation of a spin out company from an academic institute is an important step for commercialisation of a product or solution.
The Targeted Translation Research Accelerator (TTRA), a Medical Research Future Fund initiative delivered by MTPConnect, is supporting new research approaches to improve the prevention, diagnosis, treatment and management of diabetes, cardiovascular disease and their related complications. For three TTRA Research Projects funded through Rounds 1 and 2, the structure of the funding and the support offered through the program enabled them to spin out from their respective universities to take advantage of these substantial
benefits. Read on to find out more about the spin out journeys for Nanomedx, Torch Recruit and Endo Axiom!
Recently changing name from Gammasonics Institute for Medical Research,
today Globalsonics Research Pty Ltd is known in Australia as an organisation dedicated to research and development in the area of radiation measurement. After more than 40 years Globalsonics has built up an extensive knowledge in the area of science, medicine and industry. Our mission is to find solutions and encourage innovation in these critical sectors. Learn more in our Sector Directory.
|